IL94070A0 - Phosphorylated plasminogen activator,its preparation and pharmaceutical compositions containing it - Google Patents

Phosphorylated plasminogen activator,its preparation and pharmaceutical compositions containing it

Info

Publication number
IL94070A0
IL94070A0 IL94070A IL9407090A IL94070A0 IL 94070 A0 IL94070 A0 IL 94070A0 IL 94070 A IL94070 A IL 94070A IL 9407090 A IL9407090 A IL 9407090A IL 94070 A0 IL94070 A0 IL 94070A0
Authority
IL
Israel
Prior art keywords
phosphorylated
plasminogen activator
pro
preparation
pharmaceutical compositions
Prior art date
Application number
IL94070A
Other languages
English (en)
Original Assignee
Franceso Blasi
Stoppelli Maria Patrizia
Mastronicola Maria Rosaria
Karen Gjersing Welinder
Correas Isabel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Franceso Blasi, Stoppelli Maria Patrizia, Mastronicola Maria Rosaria, Karen Gjersing Welinder, Correas Isabel filed Critical Franceso Blasi
Publication of IL94070A0 publication Critical patent/IL94070A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL94070A 1989-04-14 1990-04-12 Phosphorylated plasminogen activator,its preparation and pharmaceutical compositions containing it IL94070A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK182289A DK182289D0 (da) 1989-04-14 1989-04-14 Modifikation af proteiner

Publications (1)

Publication Number Publication Date
IL94070A0 true IL94070A0 (en) 1991-01-31

Family

ID=8108312

Family Applications (1)

Application Number Title Priority Date Filing Date
IL94070A IL94070A0 (en) 1989-04-14 1990-04-12 Phosphorylated plasminogen activator,its preparation and pharmaceutical compositions containing it

Country Status (16)

Country Link
US (2) US5416006A (xx)
EP (1) EP0422198B1 (xx)
JP (1) JPH03505530A (xx)
KR (1) KR920700285A (xx)
AT (1) ATE120797T1 (xx)
AU (1) AU623522B2 (xx)
CA (1) CA2031210A1 (xx)
DE (1) DE69018361T2 (xx)
DK (1) DK182289D0 (xx)
ES (1) ES2072432T3 (xx)
HU (1) HUT56130A (xx)
IL (1) IL94070A0 (xx)
NZ (1) NZ233321A (xx)
PT (1) PT93755A (xx)
WO (1) WO1990012872A1 (xx)
ZA (1) ZA902747B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE182336T1 (de) * 1993-05-28 1999-08-15 Chiron Corp Peptidinhibitoren der urokinaserezeptor-aktivität
DE69432608T2 (de) 1993-06-01 2004-02-26 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Expression von inhibitoren vom plasminogenaktivator vom urokinasetyp
US6248715B1 (en) * 1993-06-01 2001-06-19 Chiron Corporation Method of treating a urokinase-type plasminogen activator-mediated disorder
US5994309A (en) 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
US6936587B1 (en) * 1997-07-25 2005-08-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions
EP1477800A4 (en) * 2002-01-31 2005-08-17 Gl Sciences Inc METHOD AND APPARATUS FOR AMINO ACID, PEPTIDE, PROTEIN, SACCHARIDE OR LIPID ANALYSIS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190711B1 (en) * 1985-02-07 1989-04-26 Kowa Company, Ltd. Monoclonal antibodies to tissue plasminogen activator derived from human normal cells
GB8623823D0 (en) * 1986-10-03 1986-11-05 Sandoz Ltd Therapeutic lysis of fibrin blood clots

Also Published As

Publication number Publication date
AU623522B2 (en) 1992-05-14
DK182289D0 (da) 1989-04-14
JPH03505530A (ja) 1991-12-05
EP0422198A1 (en) 1991-04-17
ATE120797T1 (de) 1995-04-15
US5688503A (en) 1997-11-18
ES2072432T3 (es) 1995-07-16
DE69018361T2 (de) 1995-08-31
NZ233321A (en) 1991-09-25
HUT56130A (en) 1991-07-29
PT93755A (pt) 1990-11-20
WO1990012872A1 (en) 1990-11-01
AU5541190A (en) 1990-11-16
DE69018361D1 (de) 1995-05-11
US5416006A (en) 1995-05-16
KR920700285A (ko) 1992-02-19
EP0422198B1 (en) 1995-04-05
CA2031210A1 (en) 1990-10-15
ZA902747B (en) 1991-01-30

Similar Documents

Publication Publication Date Title
WO1991009118A3 (en) Activatable fibrinolytic and anti-thrombotic proteins
ATE79273T1 (de) Stabilisierte zusammensetzungen von menschlichen aktivatoren des gewebeplasminogens.
MY103189A (en) Nor-statine and nor-cyclostatine polypeptides
HUT58812A (en) Process for producing tissue plasminogen activator (t-pa) zimogenes and compositions containing them as active components
DK1029921T3 (da) Serpinresistent t-PA, mutanter, gener
JPS56139418A (en) Fibronectin composition and isolation therefor
IL80659A (en) Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them
AU2036188A (en) New tissue plasminogen activator
IL94070A0 (en) Phosphorylated plasminogen activator,its preparation and pharmaceutical compositions containing it
DK302288A (da) Vaevsplasminogenaktivator med modificeret kringledomaene
ES8703521A1 (es) Procedimiento para determinar un activador de plasminogeno
NO860089L (no) Fremgangsmaate til bestemmelse av den fibrinolytiske tilstanden for plasma.
IL86058A (en) Specifically glycosylates urokinase-type plasminogen activators, their preparation, hybrid vectors and transformed yeast containing them and pharmaceutical compositions containing such activators
DK506683A (da) Fibrinolytiske enzymer, fremgangsmaader til fremstilling deraf og farmaceutiske midler indeholdende dem
EP0339505A3 (en) Monoclonal antibodies to tissue plasminogen activator (t-pa) which prolong its functional half-life
Lee et al. Kinetic analysis of covalent hybrid plasminogen activators: effect of cyanogen bromide-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation
AU7037591A (en) Stabilization of t-pa pro
IE872688L (en) Thrombolytic therapy
ES2122837A1 (es) Mezcla gaseosa y procedimiento para prepararla.
EP0292326A3 (en) Modified enzyme
EP0297816A3 (en) Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
AU6205390A (en) Pharmaceutical compositions
Hoem et al. Reduced cofactor function of human high molecular weight kininogen induced by rat plasma kallikrein
Collen Fibrinspezifische thrombolytische Substanzen
GB8604851D0 (en) Immunosorbent-amidolytic method